31
Participants
Start Date
February 1, 2019
Primary Completion Date
April 30, 2023
Study Completion Date
November 30, 2023
Belimumab
Sub-cutaneous injection
Rituximab
IV infusion 1g x 2
Prednisolone
20mg prednisolone tapering dose
Addenbrooke's Hospital, Cambridge
Glasgow Royal Infirmary, Glasgow
Imperial College London, London
Royal Free Hospital, London
Royal Freemann Hospital, Newcastle
Nottingham University Hospitals, Nottingham
Collaborators (2)
GlaxoSmithKline
INDUSTRY
Medical Research Council
OTHER_GOV
Imperial College London
OTHER
University College, London
OTHER
Newcastle University
OTHER
University of Glasgow
OTHER
University of Cambridge
OTHER
Rachel Jones
OTHER